Farglitazar

Farglitazar is a PPARγ agonist that has significant therapeutic benefits such as glycemic control in type 2 diabetic patients.

Product Specifications

CAS Number

[196808-45-4]

Product Name Alternative

GI262570; GI262570X

UNSPSC

12352005

Target

PPAR

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/farglitazar.html

Concentration

10mM

Purity

99.50

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=CC=C1)C2=C(C=CC=C2)N[C@H](C(O)=O)CC3=CC=C(C=C3)OCCC4=C(C)OC(C5=CC=CC=C5)=N4

Molecular Formula

C34H30N2O5

Molecular Weight

546.61

References & Citations

[1]Chen L, Yang B, McNulty JA, et al. GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther. 2005;312 (2) :718-725.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 3

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-89578DL594 0.1 mL

Rabbit Monoclonal Complement Component C5a Antibody (215) [DyLight 594]

View Details

MBS9422907-01 0.005 mg

Recombinant Human C-C motif chemokine 22 protein (CCL22)

View Details

MBS9422907-02 0.02 mg

Recombinant Human C-C motif chemokine 22 protein (CCL22)

View Details

MBS9422907-03 0.1 mg

Recombinant Human C-C motif chemokine 22 protein (CCL22)

View Details

MBS9422907-04 0.25 mg

Recombinant Human C-C motif chemokine 22 protein (CCL22)

View Details

MBS9422907-05 0.5 mg

Recombinant Human C-C motif chemokine 22 protein (CCL22)

View Details